With the employment of the Clinical Proteomic Tumor Analysis Consortium (CPTAC), the protein level of MMP9 and Vimentin were positively associated with CD44 in ccRCC tissues (Fig. 7F). The gene discussed is CD44; the disease is nonpapillary renal cell carcinoma.